We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.71B
AUM Growth
+$22.3M
Cap. Flow
+$39.8M
Cap. Flow %
1.07%
Top 10 Hldgs %
25.16%
Holding
1,048
New
35
Increased
379
Reduced
268
Closed
25

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$23.1M
2
BIIB icon
Biogen
BIIB
+$13.4M
3
CAT icon
Caterpillar
CAT
+$12.5M
4
CNC icon
Centene
CNC
+$11.3M
5
AFL icon
Aflac
AFL
+$10.3M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$19.2M
2
TSCO icon
Tractor Supply
TSCO
+$13.9M
3
LUV icon
Southwest Airlines
LUV
+$13.2M
4
RF icon
Regions Financial
RF
+$12.9M
5
JCI icon
Johnson Controls International
JCI
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 17.4%
2 Financials 16.23%
3 Healthcare 13.52%
4 Consumer Discretionary 13.51%
5 Industrials 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNK icon
451
Cinemark Holdings
CNK
$4.24B
$656K 0.02%
17,416
+1,092
+7% +$41.5K
DELL icon
452
Dell
DELL
$262B
$655K 0.02%
31,862
+9,086
+40% +$196K
RNR icon
453
RenaissanceRe
RNR
$13.3B
$655K 0.02%
4,732
– –
SNPS icon
454
Synopsys
SNPS
$74.4B
$655K 0.02%
7,868
-448
-5% -$39.4K
LPX icon
455
Louisiana-Pacific
LPX
$5.06B
$653K 0.02%
22,712
– –
FTAI icon
456
FTAI Aviation
FTAI
$21.1B
$651K 0.02%
47,777
+15,926
+50% +$235K
HES
457
DELISTED
Hess
HES
$648K 0.02%
12,796
-1,680
-12% -$82.3K
SNDX icon
458
Syndax Pharmaceuticals
SNDX
$1.69B
$644K 0.02%
45,276
– –
EVHC
459
DELISTED
Envision Healthcare Holdings Inc
EVHC
$643K 0.02%
16,728
-1,360
-8% -$50.8K
FLS icon
460
Flowserve
FLS
$9.71B
$641K 0.02%
14,790
-442
-3% -$19.2K
DLR icon
461
Digital Realty Trust
DLR
$69.7B
$640K 0.02%
6,072
+594
+11% +$62.7K
AZN icon
462
AstraZeneca
AZN
$263B
$638K 0.02%
9,129
– –
MRVL icon
463
Marvell Technology
MRVL
$168B
$635K 0.02%
+30,250
New +$693K
TRIP icon
464
TripAdvisor
TRIP
$1.65B
$630K 0.02%
15,402
-2,448
-14% -$95.7K
ASND icon
465
Ascendis Pharma A/S
ASND
$16B
$627K 0.02%
+9,588
New +$539K
EME icon
466
Emcor
EME
$35.2B
$620K 0.02%
7,956
– –
PF
467
DELISTED
Pinnacle Foods, Inc.
PF
$618K 0.02%
11,424
-21,448
-65% -$1.24M
ILG
468
DELISTED
ILG, Inc Common Stock
ILG
$611K 0.02%
19,652
+1,054
+6% +$33K
FBIN icon
469
Fortune Brands Innovations
FBIN
$5.88B
$609K 0.02%
12,093
+676
+6% +$37.7K
CF icon
470
CF Industries
CF
$19.2B
$607K 0.02%
16,100
-4,312
-21% -$176K
CVBF icon
471
CVB Financial
CVBF
$3.94B
$607K 0.02%
26,796
-22,596
-46% -$531K
DCI icon
472
Donaldson
DCI
$10.9B
$605K 0.02%
13,420
+176
+1% +$8.43K
SR icon
473
Spire
SR
$4.72B
$605K 0.02%
8,364
+612
+8% +$41.7K
VIAB
474
DELISTED
Viacom Inc. Class B
VIAB
$595K 0.02%
19,152
-2,912
-13% -$94.1K
DEI icon
475
Douglas Emmett
DEI
$1.98B
$590K 0.02%
16,060
– –
17 18
19
20 21

Similar funds

GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Elkfork Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Elkfork Partners held 1,048 positions worth $3.71B, up 0.6% from $3.69B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Elkfork Partners's Q1 2018 filing shows 35 new, 379 increased, 268 reduced and 25 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 49,308 shares worth $5.87M. The largest sale was Express Scripts Holding Company, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q1 2018 buy was Alnylam Pharmaceuticals: 49,308 shares worth $5.87M.
  • Elkfork Partners added most to Boeing in Q1 2018, an estimated $23.1M increase.
  • Elkfork Partners's biggest Q1 2018 reduction was Express Scripts Holding Company, cutting an estimated $19.2M.
  • Elkfork Partners fully exited Spirit Airlines, Inc. in Q1 2018, selling an estimated $4.93M.
  • Elkfork Partners's ten largest holdings make up 25% of its $3.71B portfolio in Q1 2018.
  • Elkfork Partners opened 35 new positions and closed 25 in Q1 2018.
  • Elkfork Partners's portfolio value rose 0.6% quarter-over-quarter to $3.71B.

Based on Elkfork Partners's 13F filing for Q1 2018, filed 10 May 2018.